-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QUCPgICdCWj6EhodG3u3XsuLAGFBjYno4Jz0lE2ts/IyQ7B0Ro90TYLb8B4+CH5j oiRXPyNuICE8qvQu4POBaw== 0001140361-10-028487.txt : 20100706 0001140361-10-028487.hdr.sgml : 20100705 20100706172414 ACCESSION NUMBER: 0001140361-10-028487 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100701 FILED AS OF DATE: 20100706 DATE AS OF CHANGE: 20100706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SABEL IVAN R CENTRAL INDEX KEY: 0001217563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 10939763 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0303 4 2010-07-01 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217563 SABEL IVAN R TWO BETHESDA METRO CENTER SUITE 1200 BETHESDA MD 20814 1 1 0 0 Chairman of the Board Common Stock 2010-07-01 4 S 0 56798 17.7572 D 153600 D Common Stock 1100 I IRA Common Stock 1100 I Spouse's IRA Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 100000 100000 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 90000 90000 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $17.66 to $17.83. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. These shares include restricted shares that became fully vested upon the reporting person's retirement as an executive officer, effective as of June 30, 2010. All restricted shares held by the reporting person are now fully vested. This option was fully vested on June 23, 2005. /s/ Teri L. Champ, Attorney-in-Fact for Ivan R. Sabel 2010-07-06 -----END PRIVACY-ENHANCED MESSAGE-----